TIMP-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TIMP-1 monoclonal antibodies for research focused on Tissue Inhibitor of Metalloproteinases 1 (TIMP-1). TIMP-1 Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TIMP-1 is a critical regulator of matrix metalloproteinases (MMPs), which are involved in the degradation of extracellular matrix components. Through MMP inhibition, TIMP-1 plays a vital role in tissue remodeling, wound healing, and the regulation of inflammatory responses. TIMP-1 dysregulation has been implicated in various pathological conditions, including cancer and cardiovascular diseases, making it an important target for therapeutic interventions. Researchers can explore TIMP-1's role in cellular processes using specific monoclonal antibodies validated for multiple experimental approaches. Understanding TIMP-1's functions and regulatory mechanisms can provide valuable insights into disease development and potential treatments. TIMP-1 research continues to reveal new aspects of its biological significance in both normal physiology and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TIMP-1's role in human health and disease.